Limitations of stereotactic biopsy in the initial management of gliomas.
about
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingCurrent trends in the surgical management and treatment of adult glioblastomaManagement of low-grade glioma.Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testingAdvanced imaging techniques in brain tumors.Prognostic value of blood flow measurements using arterial spin labeling in gliomasGlioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and scienceDoes early resection of presumed low-grade glioma improve survival? A clinical perspective.Molecular imaging of gliomas with PET: opportunities and limitations.Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomasCorrelation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles.Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumorsFeasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicinePreclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible.Extracellular RNAs: development as biomarkers of human disease.Rapid Intraoperative Molecular Characterization of Glioma.Achieving Higher Diagnostic Results in Stereotactic Brain Biopsy by Simple and Novel Technique.Visualization of heterogeneity and regional grading of gliomas by multiple features using magnetic resonance-based clustered images.Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy.Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?ExRNA in Biofluids as Biomarkers for Brain Tumors.Neurologic Applications of PET/MR Imaging.Differentiating low- and high-grade pediatric brain tumors using a continuous-time random-walk diffusion model at high b-values.Usefulness of positron emission tomographic studies for gliomas.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.Rapid progression of early delayed radiation effect in pleomorphic xanthoastrocytomaMolecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft modelA Single-Center Cost Analysis of Treating Primary and Metastatic Brain Cancers with Either Brain Laser Interstitial Thermal Therapy (LITT) or Craniotomy.Surgical resection versus watchful waiting in low-grade gliomas.Tumor blood volume: a prognostic biomarker for anaplastic astrocytomas?Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens.
P2860
Q26796223-A6D94BF5-378E-459A-B028-A0643ACF69A8Q26799854-B2010F14-225F-4E26-926B-2E43E14704C9Q30436353-D90F7F8E-E585-4AFB-8512-A8D28B939254Q30810936-BF7BA713-51EC-40D1-AAC2-CC801F50DBFBQ33517391-E8AA7C32-87A9-4A40-A63B-E285B866ECACQ33727772-2B934B39-F6B1-4914-9D22-6E8D01265C95Q33746514-52A65C3F-2D4A-4214-85F0-2002A8C284B9Q33867304-64BD9ECD-0067-45CA-AC11-A84DA3708E16Q33961188-AB985996-EB8D-4D26-B36B-E7796FD186C4Q34130469-62D668B5-C667-4121-8D97-649BF3CB1DE9Q34369456-3869C523-338E-495E-B2DB-E379CE49EF4EQ34498352-F86D3E70-A611-4C7B-872E-86C8C45DB4EDQ34722450-84ED2CFD-1C89-4566-A59B-A397778264ECQ34971940-EFD18A2F-DA3A-43FF-9A6D-2765753C1164Q34988771-B9ABAE22-5FE2-4DD5-999D-3ACB66E4CD1BQ35083593-3730FEB7-CA5F-4612-85E1-99109C6A557CQ35213599-CE42BF45-E9CB-42AD-8E16-C1C25E3810F1Q35765099-6CB28E15-6170-44B6-BFF8-444C2BD7BB2BQ35807945-2B5FFFC7-DFCA-457D-99E1-CBBFFCB4F666Q35840588-114D9B91-63CC-4F5B-AB44-A56E7E814D23Q35967155-28996E3A-AC0A-4617-A307-1C4548D778EFQ36006446-EDAFFDE7-C079-4CCD-8639-C4C16AA0D2D5Q36914510-0C179B97-B053-4FE7-BC7C-F47A1CDCA3B3Q36929134-2ED9651F-2F84-4C96-9A87-F3AC00B61C0DQ37125317-CF45B88C-FBF0-4273-B642-D2EB2494ED92Q37174245-CA8CA703-6A03-42BA-9372-C4A9B2E6E8FFQ37215750-1C247DEF-0A50-41F2-9FF0-5A7700558A5AQ38168686-C75E50E1-3068-4CFB-A8C8-AFFBD1B11326Q38615302-90E52539-7C02-448B-8F6B-A6C9EBE6BDABQ38781031-4B3CDCD2-BD63-465C-B881-ADE6E1CD28F5Q38846608-B05CA5F8-1341-4FC3-BD04-DEE38E1E9F27Q41652678-0D3A42B6-2E55-4686-A75D-2169589D827DQ41965733-9FC862B1-C85B-4879-9008-2BE7E534DEA1Q41994160-2705FF37-2645-4495-8F1E-17E63A4A887AQ42029673-E5FF0F3E-1464-4FD5-9EA3-0FF434A5390DQ42364589-7BC66644-516D-4E02-B0C7-4D8A9BC5D1BAQ47096999-3B3458E1-047D-4C56-B791-A6BAAF440523Q47379204-214B7711-A76D-476F-AFC8-08B9C387AFB8Q48641566-5AD2230E-772E-4D49-A806-5722BE10309DQ48760397-C336FA5C-9577-422C-8478-2E6234A13F07
P2860
Limitations of stereotactic biopsy in the initial management of gliomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Limitations of stereotactic biopsy in the initial management of gliomas.
@ast
Limitations of stereotactic biopsy in the initial management of gliomas.
@en
type
label
Limitations of stereotactic biopsy in the initial management of gliomas.
@ast
Limitations of stereotactic biopsy in the initial management of gliomas.
@en
prefLabel
Limitations of stereotactic biopsy in the initial management of gliomas.
@ast
Limitations of stereotactic biopsy in the initial management of gliomas.
@en
P2093
P1433
P1476
Limitations of stereotactic biopsy in the initial management of gliomas
@en
P2093
D Abi-Said
D M Wildrick
R J Jackson
Z L Gokaslan
P304
P356
10.1093/NEUONC/3.3.193
10.1215/S1522851701000011
P577
2001-07-01T00:00:00Z